综合性行为干预在延缓慢性阻塞性肺疾病患者疾病进展中的作用观察

Effect of Comprehensive Behavioral Intervention on Delaying Disease Progression in patients with Chronic Obstructive Pulmonary Disease

目的:探讨综合性行为干预方案对慢性阻塞性肺疾病(COPD)患者病情进展的影响。方法:选取2015年3月至2017年5月COPD患者106例,是否接受综合行为干预将其分为观察组和对照组,其中对照组患者仅接受常规治疗,观察组患者在常规治疗基础上联合综合性行为干预,两组患者均于6个月后接受呼吸功能评估,并对其生活质量、COPD急性发作次数进行评估记录。结果:观察组患者干预6个月后FEV1、FEV1%、急性发作次数均明显优于对照组,差异具有统计学意义(P<0.05);观察组患者干预6个月时SGRQ评估量表中社会心理影响、活动能力、呼吸症状、总分均明显低于对照组,差异具有统计学意义(P<0.05)。结论:对慢性阻塞性肺疾病患者实施综合性行为干预,可有效改善患者肺功能,提高其生活质量,有助于延缓患者病情恶化程度,对于疾病进展控制具有十分积极的作用,建议在临床推广应用。

Objective： To investigate the effects of comprehensive behavioral interventions on the progression of patients with chronic obstructive pulmonary disease（ COPD）. Methods： 106 cases of COPD in our hospital from March 2015 to May 2017 were selected. If they received comprehensive behavioral intervention,they were divided into observation group and control group. The control group received conventional treatment only,while the observation group received comprehensive behavioral intervention on the basis of conventional treatment. The patients of two groups were received respiratory function assessment after 6 months,and their quality of life and the number of acute attacks of COPD were evaluated. Results： After 6 months＇ intervention,the FEV1,FEV1% and the number of acute attacks in the observation group were significantly better than those in the control group,the difference was statistically significant（ P〈0.05）. In the observation group,the social psychological influence,activity,respiratory symptoms and total scores in the SGRQ assessment scale were significantly lower than those in the control group at 6 months. The difference was statistically significant（ P〈0.05）. Conclusion： The implementation of comprehensive behavioral intervention in patients with COPD can effectively improve lung function and quality of life of patients with chronic obstructive pulmonary disease,help to delay the progression of patients＇ condition,and has a very positive effect on the control of disease progression. It is recommended for clinical application.